表观遗传学
DNA甲基化
生物
表观基因组
组蛋白
表观遗传学
癌症表观遗传学
慢性淋巴细胞白血病
遗传学
表观遗传疗法
基因
癌症研究
白血病
基因表达
作者
Larry Mansouri,Justyna A. Wierzbińska,Christoph Plass,Richard Rosenquist
标识
DOI:10.1016/j.semcancer.2018.02.001
摘要
Deregulated transcriptional control caused by aberrant DNA methylation and/or histone modifications is a hallmark of cancer cells. In chronic lymphocytic leukemia (CLL), the most common adult leukemia, the epigenetic ‘landscape’ has added a new layer of complexity to our understanding of this clinically and biologically heterogeneous disease. Early studies identified aberrant DNA methylation, often based on single gene promoter analysis with both biological and clinical impact. Subsequent genome-wide profiling studies revealed differential DNA methylation between CLLs and controls and in prognostics subgroups of the disease. From these studies, it became apparent that DNA methylation in regions outside of promoters, such as enhancers, is important for the regulation of coding genes as well as for the regulation of non-coding RNAs. Although DNA methylation profiles are reportedly stable over time and in relation to therapy, a higher epigenetic heterogeneity or ‘burden’ is seen in more aggressive CLL subgroups, albeit as non-recurrent ‘passenger’ events. More recently, DNA methylation profiles in CLL analyzed in relation to differentiating normal B-cell populations revealed that the majority of the CLL epigenome reflects the epigenomes present in the cell of origin and that only a small fraction of the epigenetic alterations represents truly CLL-specific changes. Furthermore, CLL patients can be grouped into at least three clinically relevant epigenetic subgroups, potentially originating from different cells at various stages of differentiation and associated with distinct outcomes. In this review, we summarize the current understanding of the DNA methylome in CLL, the role of histone modifying enzymes, highlight insights derived from animal models and attempts made to target epigenetic regulators in CLL along with the future directions of this rapidly advancing field.
科研通智能强力驱动
Strongly Powered by AbleSci AI